TCO-MMAE + SQL 70 - Shasqi
Alternative Names: TCO-MMAE + SQL 70Latest Information Update: 07 Jun 2023
Price :
$50 *
At a glance
- Originator Shasqi
- Class Antineoplastics; Auristatins; Biopolymers; Cyclic hydrocarbons; Small molecules; Tetrazoles
- Mechanism of Action Apoptosis stimulants; Mitosis inhibitors; Tubulin polymerisation inhibitors
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity No
Highest Development Phases
- Preclinical Solid tumours
Most Recent Events
- 01 Jun 2023 Shasqi and Johnson and Johnson Innovation agree to co-develop SQL 70 biopolymer
- 08 Apr 2022 Preclinical trials in Solid tumours in USA (Parenteral)
- 08 Apr 2022 Pharmacodynamics data from a preclinical study in Solid tumours presented at the 113th Annual Meeting of the American Association for Cancer Research (AACR-2022)